Back to search
Atrial Fibrillation, Myocardial Infarction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Atrial Fibrillation, Myocardial Infarction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Atrial Fibrillation, Myocardial Infarction trials you may qualify forTo validate the prognostic importance of the burden of new-onset atrial fibrillation (NOAF) complicating acute myocardial infarction (AMI) in a prospectively de…
The goal of this observational study is to learn if the novel biomarker Heat shock protein 47 (HSP47) can be used as a prognostic marker for vascular disease in…
At the moment, the invasive strategy for the infarct-associated coronary artery in patients with ST-segment elevation myocardial infarction (STEMI) necessary to…
The goal of this observational study is to better understand the role of measuring troponin (a protein measured by a blood test) and coronary imaging in patient…
Intracranial hemorrhage is a condition characterized by high mortality rates and suboptimal functional outcomes. It precipitates both direct brain injury and su…
Myocardial infarction with non-obstructive coronary arteries (MINOCA) (i.e.\<50% stenoses) on coronary angiography) is an underappreciated clinical entity conce…
Patients with Acute Coronary Syndrome associated with de novo atrial fibrillation are randomized to benefit from either a conventional therapy associating dual…
To investigate the prognostic impacts of the atrial fibrillation burden (AFb) in acute myocardial infarction (AMI) patients who developed paroxysmal new-onset a…